Understanding terminology of potential COVID-19 medical countermeasures | COVID MyStudies App | Reference panel for COVID-19 test developers

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on May 27, 2020 include: Coronavirus (COVID-19) Updates: June 2, 2020: Daily Roundup: FDA actions on food safety, guidance on single-member IRBs, an authorized NASA ventilator, and more June 2, 2020: Pandemic Challenges Highlight the Importance of the New Era of Smarter Food Safety June 1, 2020: Remarks by Commissioner Stephen Hahn, M.D. — The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned (with video) June 1, 2020: FDA Takes Action to Protect Public Health; Increase Supply of Alcohol-Based Hand Sanitizer May 29, 2020: Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic, by Stephen M. Hahn, M.D., Commissioner of Food and Drugs May 29, 2020: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection May 27, 2020: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection Also see the features and Emergency Use Authorization Updates below